Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jul 22, 2022

50715_rns_2022-07-22_f901177b-efc0-4fea-a5e2-c226ea7ef043.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

22 July 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Descriptionof relevantsecurities Nature of dealings Purchase/ Sale Totalnumber ofsharesinvolved Totalamount paid/ received Highest (H)prices paid/ received Lowest (L)prices paid/ received
CICC FinancialTrading Limited 21 July 2022 Other typesof securities(e.g. equityswaps) Dealing in pre-existingindex-tracking ETFs Sale 330 $13,513.5000 $40.9500 $40.9500
Other typesof securities(e.g. equityswaps) Hedging related to dealing inpre-existing index-tracking ETFs Purchase 330 $13,505.2500 $40.9250 $40.9250

End

Public Disclosure Form

==> picture [71 x 43] intentionally omitted <==

Note:

CICC Financial Trading Limited is an exempt principal trader connected with the Offeror.

Dealings were made for its own account.

CICC Financial Trading Limited is ultimately owned by China International Capital Corporation Limited.

The other types of securities refer to Vanguard FTSE Emerging Markets ETF (VWO US Equity, ISIN US9220428588), which contains more than 1 percent share capital of 1171.HK, and price per unit is in USD.